Report an error

Spotted something inaccurate in “Bispecific HER2 Antibody Zanidatamab Shows Promise Against Gastroesophageal Tumors”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.